女性下尿路症状临床指南(第二版)

2021-03-01 日本泌尿外科协会 Int J Urol . 2021 Mar 1.

本文是2019年9月发布的《日本女性下尿路症状临床临床指南》(第二版)的英文摘译版本。该指南共212页,涵盖了除尿失禁以外的女性下尿路症状,在全球范围内独一无二。它们分别包含 "初级治疗 "和 "专业

中文标题:

女性下尿路症状临床指南(第二版)

英文标题:

Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition)

发布机构:

日本泌尿外科协会

发布日期:

2021-03-01

简要介绍:

本文是2019年9月发布的《日本女性下尿路症状临床临床指南》(第二版)的英文摘译版本。该指南共212页,涵盖了除尿失禁以外的女性下尿路症状,在全球范围内独一无二。它们分别包含 "初级治疗 "和 "专业治疗 "两种算法。这些指南由6章组成,共涉及26个临床问题,包括。(一)治疗算法;(二)什么是女性下尿路症状;(三)流行病学与生活质量;(四)病理与疾病;(五)诊断;(六)治疗。当患者的症状主要涉及到排尿和排尿后症状时,应考虑进行专业治疗。当排空症状与储尿症状同时出现时,应测量残余尿量,如果残余尿量<100 mL,则优先考虑储尿症状的诊断和治疗,如果尿量≥100 mL,则应考虑专科治疗。当储尿症状为首发症状时,则按首发治疗算法进行治疗。难治性膀胱过度活跃的专业治疗包括肉毒杆菌毒素注射和骶神经刺激。对于压力性尿失禁,则需进行手术治疗,如尿道吊带。引起排尿症状和排尿后症状的两个原因是下尿路梗阻和排尿肌活动不足(膀胱活动不足)。机械性下尿路梗阻,如盆腔器官脱垂,有望通过手术改善。

相关资料下载:
[AttachmentFileName(sort=1, fileName=JCS临床指南:女性下尿路症状(第2版.pdf)] GetToolGuiderByIdResponse(projectId=1, id=552c01c0020e106c, title=女性下尿路症状临床指南(第二版), enTitle=Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition), guiderFrom=Int J Urol . 2021 Mar 1., authorId=0, author=, summary=本文是2019年9月发布的《日本女性下尿路症状临床临床指南》(第二版)的英文摘译版本。该指南共212页,涵盖了除尿失禁以外的女性下尿路症状,在全球范围内独一无二。它们分别包含 "初级治疗 "和 "专业, cover=https://img.medsci.cn/2021314/1615737373905_2020535.jpg, journalId=0, articlesId=null, associationId=1069, associationName=日本泌尿外科协会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Mar 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>本文是2019年9月发布的《日本女性下尿路症状临床临床指南》(第二版)的英文摘译版本。该指南共212页,涵盖了除尿失禁以外的女性下尿路症状,在全球范围内独一无二。它们分别包含 "初级治疗 "和 "专业治疗 "两种算法。这些指南由6章组成,共涉及26个临床问题,包括。(一)治疗算法;(二)什么是女性下尿路症状;(三)流行病学与生活质量;(四)病理与疾病;(五)诊断;(六)治疗。当患者的症状主要涉及到排尿和排尿后症状时,应考虑进行专业治疗。当排空症状与储尿症状同时出现时,应测量残余尿量,如果残余尿量&lt;100 mL,则优先考虑储尿症状的诊断和治疗,如果尿量&ge;100 mL,则应考虑专科治疗。当储尿症状为首发症状时,则按首发治疗算法进行治疗。难治性膀胱过度活跃的专业治疗包括肉毒杆菌毒素注射和骶神经刺激。对于压力性尿失禁,则需进行手术治疗,如尿道吊带。引起排尿症状和排尿后症状的两个原因是下尿路梗阻和排尿肌活动不足(膀胱活动不足)。机械性下尿路梗阻,如盆腔器官脱垂,有望通过手术改善。</p>, tagList=[TagDto(tagId=33613, tagName=下尿路症状)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=33613, guiderKeyword=下尿路症状, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11191, appHits=404, showAppHits=0, pcHits=687, showPcHits=10787, likes=3, shares=38, comments=21, approvalStatus=1, publishedTime=Mon Mar 15 00:36:48 CST 2021, publishedTimeString=2021-03-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 14 23:56:22 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:36:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=JCS临床指南:女性下尿路症状(第2版.pdf)])
JCS临床指南:女性下尿路症状(第2版.pdf
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1202367, encodeId=dc40120236ea2, content=好好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f932612619, createdName=ycl800, createdTime=Mon Mar 14 05:18:47 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200416, encodeId=c3ba1200416a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3436526779, createdName=ms1000000788304529, createdTime=Mon Mar 07 23:58:15 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181565, encodeId=24c9118156518, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f5f5472733, createdName=ms3000001138543316, createdTime=Thu Jan 06 22:02:29 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083118, encodeId=63e7108311859, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Dec 22 16:55:23 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079657, encodeId=ecff10e965726, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af76160002, createdName=ms2000000338181930, createdTime=Mon Dec 13 19:30:16 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2022-03-14 ycl800

    好好!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1202367, encodeId=dc40120236ea2, content=好好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f932612619, createdName=ycl800, createdTime=Mon Mar 14 05:18:47 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200416, encodeId=c3ba1200416a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3436526779, createdName=ms1000000788304529, createdTime=Mon Mar 07 23:58:15 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181565, encodeId=24c9118156518, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f5f5472733, createdName=ms3000001138543316, createdTime=Thu Jan 06 22:02:29 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083118, encodeId=63e7108311859, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Dec 22 16:55:23 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079657, encodeId=ecff10e965726, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af76160002, createdName=ms2000000338181930, createdTime=Mon Dec 13 19:30:16 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2022-03-07 ms1000000788304529

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1202367, encodeId=dc40120236ea2, content=好好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f932612619, createdName=ycl800, createdTime=Mon Mar 14 05:18:47 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200416, encodeId=c3ba1200416a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3436526779, createdName=ms1000000788304529, createdTime=Mon Mar 07 23:58:15 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181565, encodeId=24c9118156518, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f5f5472733, createdName=ms3000001138543316, createdTime=Thu Jan 06 22:02:29 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083118, encodeId=63e7108311859, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Dec 22 16:55:23 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079657, encodeId=ecff10e965726, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af76160002, createdName=ms2000000338181930, createdTime=Mon Dec 13 19:30:16 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2022-01-06 ms3000001138543316

    太棒了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1202367, encodeId=dc40120236ea2, content=好好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f932612619, createdName=ycl800, createdTime=Mon Mar 14 05:18:47 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200416, encodeId=c3ba1200416a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3436526779, createdName=ms1000000788304529, createdTime=Mon Mar 07 23:58:15 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181565, encodeId=24c9118156518, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f5f5472733, createdName=ms3000001138543316, createdTime=Thu Jan 06 22:02:29 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083118, encodeId=63e7108311859, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Dec 22 16:55:23 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079657, encodeId=ecff10e965726, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af76160002, createdName=ms2000000338181930, createdTime=Mon Dec 13 19:30:16 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-22 D-House

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1202367, encodeId=dc40120236ea2, content=好好!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f932612619, createdName=ycl800, createdTime=Mon Mar 14 05:18:47 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200416, encodeId=c3ba1200416a9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3436526779, createdName=ms1000000788304529, createdTime=Mon Mar 07 23:58:15 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181565, encodeId=24c9118156518, content=太棒了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9f5f5472733, createdName=ms3000001138543316, createdTime=Thu Jan 06 22:02:29 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083118, encodeId=63e7108311859, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Dec 22 16:55:23 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079657, encodeId=ecff10e965726, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af76160002, createdName=ms2000000338181930, createdTime=Mon Dec 13 19:30:16 CST 2021, time=2021-12-13, status=1, ipAttribution=)]
    2021-12-13 ms2000000338181930

    很好

    0

拓展阅读

宁泌泰胶囊在下尿路症状中临床应用中国专家共识

中国中医药信息研究会(CIATCM,China Information Association For Traditional Chinese Medicine and Pharmacy) 男科分会 · 2017-09-30

2018 AUA指南:良性前列腺增生引起的下尿路症状的手术管理

美国泌尿外科学会(AUA,American Urological Association) · 2018-05-15

2019 SIR多学科立场声明:前列腺动脉栓塞治疗良性前列腺增生引起的下尿路症状

介入放射学会(SIR,Society of Interventional Radiology) · 2019-03-26

2021 HKGS/HKUA共识:在多病共存和多重用药时代男性下尿路症状的个体化治疗

香港老年科医学会(HKGS,Hong Kong Geriatrics Society) · 2021-04-20

男性下尿路症状诊断和治疗中国专家共识

中华医学会男科学分会男性下尿路症状诊断和治疗中国专家共识编写组 · 2021-12-20